Renflexis 100 mg/1
infliximab · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Organon LLC
No Recall History
Plain English
Renflexis is a injection, powder, lyophilized, for solution containing infliximab at 100 mg/1, taken intravenous. Manufactured by Organon LLC.
Key Facts
- Brand Name
- Renflexis
- Generic Name
- infliximab
- NDC Code (Product)
78206-162- Manufacturer
- Organon LLC
- Strength
- 100 mg/1
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761054
- Drug Class
- Tumor Necrosis Factor Blocker [EPC]
- Marketing Start
- 04/21/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is Renflexis used for?
Renflexis contains infliximab. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is Renflexis a controlled substance?
Renflexis is not classified as a controlled substance by the DEA.
What is the generic name for Renflexis?
The generic name for Renflexis is infliximab. There are 6 other brand versions of infliximab.
What is the NDC code for Renflexis 100 mg/1?
The NDC (National Drug Code) for Renflexis 100 mg/1 is 78206-162, listed by Organon LLC.